Brimonidine--an alpha 2-agonist for glaucoma.
D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000068438:Brimonidine Tartrate; D002986:Clinical Trials as Topic; D000075202:Contraindications; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D011810:Quinoxalines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014987:Xerostomia / Q000139:chemically induced
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D011810:Quinoxalines; D000068438:Brimonidine Tartrate